AHA 2022 Presentation Slides | First-in-Human in vivo Crispr/Cas9 Editing
Image Modality: Illustration Table Figure
Description:
AHA 2022 Presentation Slides | First-in-Human in vivo Crispr/Cas9 Editing of the Ttr Gene by Ntla-2001 in Patients With Transthyretin Amyloidosis With Cardiomyopathy